Latest News and Press Releases
Want to stay updated on the latest news?
-
La Commission européenne commandera 1,25 million de doses de VLA2001, le vaccin à virus entier contre la COVID-19 de Valneva, en 2022 Saint-Herblain (France), le 20 juillet 2022 - Valneva SE (Nasdaq...
-
European Commission Approves Purchase Agreement Amendment for Valneva’s Inactivated COVID-19 Vaccine
European Commission to order 1.25 million doses of Valneva’s whole-virus COVID-19 vaccine VLA2001 in 2022 Saint-Herblain (France), July 20, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a...
-
EFECTE OYJ -- YHTIÖTIEDOTE – 19.7.2022 KLO 13.30 Korjaustiedote: Efecte Oyj:n puolivuotiskatsaus 1-6/2022 Efecte Oyj:n 19.7.2022 klo 8:30 julkaiseman puolivuotiskatsauksen...
-
EFECTE OYJ -- YHTIÖTIEDOTE– 19.7.2022 KLO 8.30 Efecte Oyj:n puolivuotiskatsaus 1-6/2022 – SaaS +24 %, oikaistu käyttökateprosentti +3 % 4-6/2022: Kokonaisliikevaihto kasvoi 19 % ja oli 5,3...
-
VERO BEACH, Florida, July 01, 2022 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today confirmed the July 2022 cash dividend for the Company’s...
-
TORONTO, June 30, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of...
-
VERO BEACH, Florida, June 24, 2022 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced guidance on the July 2022 cash dividend for...
-
VLA2001 devient le premier vaccin contre la COVID-19 à recevoir une autorisation de mise sur le marché de type standard en Europe. Saint Herblain (France), 24 juin 2022 – Valneva SE (Nasdaq : VALN ;...
-
VLA2001 becomes the first COVID-19 vaccine to receive a standard marketing authorization in Europe Saint Herblain (France), June 24, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a...
-
Saint Herblain (France), June 23, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of...